PharmaCyte Biotech Inc (PMCB)

[Mens et Manus]

Just a few things to keep in mind at the moment.

1. I believe it will take about 2 months to rewrite/document/update training materials etc for the PC trial.

2. As it appears to be a privital trial it will be more expensive. I believe Pharmacyte is now in a better position to apply for funding with various agencies as the pre ind meeting with the FDA is in hand. I would not be surprised if the FDA helps in this process. To me this will further delay the IND submission.

3. I expect the IND to be filed by June 2017. If earlier great.

4. We may receive positive action on the MJ etf in March. Followed by the April MJ company backed presentation.

5. Diabetes-to me a big black hole at this time????